Why United Therapeutics (UTHR) Shares Are Falling Today

Source: StockStory · 2026-09-25T01:12:58+00:00

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 4% in the afternoon session after Goldman Sachs initiated coverage of the stock with a Sell rating.

BestAIBroker analysis

Finance-aware sentiment: negative (-0.60 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 26/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: UTHR, GS.

Read the original source